Cargando…

COVID-19: is there a link between the course of infection and pharmacological agents in diabetes?

BACKGROUND: The Coronavirus disease 2019 (COVID-19) and type 2 diabetes (T2D) are two pandemics that share the dramatic impact on global mortality and economic resources. COVID-19 largely exhibits mild to moderate clinical manifestations. However, severe pneumonia with high fatality rate may occur,...

Descripción completa

Detalles Bibliográficos
Autores principales: Filardi, T., Morano, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268955/
https://www.ncbi.nlm.nih.gov/pubmed/32495299
http://dx.doi.org/10.1007/s40618-020-01318-1